Evidence map›Paper›PMID 29061178›Full record

ArticleBMC nephrology2017

Intensive procedure preferences at the end of life (EOL) in older Latino adults with end stage renal disease (ESRD) on dialysis.

Karla Gonzalez, Jesus G Ulloa, Gerardo Moreno, Oscar Echeverría, Keith Norris, Efrain Talamantes

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Palliative Care in Patients with End-Stage Renal Disease: A Meta Synthesis.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Karla GonzalezDepartment of Family Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, USA. Kagonzalez@mednet.ucla.edu.ORCID http://orcid.org/0000-0003-3140-2080
Jesus G UlloaDepartment of Surgery, University of California San Francisco, 513 Parnassus Ave, S-321, San Francisco, CA, 94143, USA.
Gerardo MorenoDepartment of Family Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, USA.
Oscar EcheverríaUCLA David Geffen School of Medicine at University of California, 10833 Le Conte Ave # 12138, Los Angeles, CA, 90095, USA.
Keith NorrisRobert Wood Johnson Foundation, Clinical Scholars Program, University of California, Los Angeles, Los Angeles, CA, USA.
Efrain TalamantesDivision of General Internal Medicine, University of California, Davis School of Medicine, 4150 V Street, Suite 2400, Sacramento, CA, 95817, USA.
University of California, Los Angeles · USLos Angeles County Department of Health Services · USUniversity of California, Davis · US

Funding

UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
The Center for Health Improvement of Minority ElderlyP30AG021684 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CAROL M MANGIONE · 2002 to 2026
$19.7M
Health IT decision support to improve medication management safety and qualityK23AG042961 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MORENO, GERARDO · 2012 to 2016
$699k
NCATS NIH HHS UL1 TR000124NIA NIH HHS K23 AG042961NIA NIH HHS P30 AG021684
6 · The paper itself

Abstract

backgroundLatinos in the U.S. are almost twice as likely to progress to End Stage Renal disease (ESRD) compared to non-Latino whites. Patients with ESRD on dialysis experience high morbidity, pre-mature mortality and receive intensive procedures at the end of life (EOL). This study explores intensive procedure preferences at the EOL in older Latino adults.

methodsSeventy-three community-dwelling Spanish- and English-Speaking Latinos over the age of 60 with and without ESRD participated in this study. Those without ESRD (n = 47) participated in one of five focus group sessions, and those with ESRD on dialysis (n = 26) participated in one-on-one semi-structured interviews. Focus group and individual participants answered questions regarding intensive procedures at the EOL. Recurring themes were identified using standard qualitative content-analysis methods. Participants also completed a brief survey that included demographics, language preference, health insurance coverage, co-morbidities, Emergency Department visits and functional limitations.

resultsThe majority of participants were of Mexican origin with mean age of 70, and there were more female participants in the non-ESRD group, compared to the ESRD dialysis dependent group. The dialysis group reported a higher number of co-morbidities and functional limitations. Nearly 69% of those in the dialysis group reported one or more emergency department visits in the past year, compared to 38% in the non-ESRD group. Primary themes centered on 1) The acceptability of a "natural" versus "invasive" procedure 2) Cultural traditions and family involvement 3) Level of trust in physicians and autonomy in decision-making.

conclusionOur results highlight the need for improved patient- and family-centered approaches to better understand intensive procedure preferences at the EOL in this underserved population of older adults.

Indexed as

Hispanic or LatinoTerminal CareAdvance Care PlanningAgedCardiopulmonary ResuscitationCase-Control StudiesDecision MakingFamily RelationsFemaleFocus GroupsGastrostomyHumansInterviews as TopicIntubation, GastrointestinalKidney Failure, ChronicMaleAdvanced care planningDialysisEnd of lifeIntensive proceduresLatinosRenal disease

Identifiers

PMID29061178
PMCPMC5654039
OpenAlexW2766127170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.